Waddell & Reed Financial Inc. increased its stake in Clorox Co (NYSE:CLX) by 1.4% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 77,814 shares of the company’s stock after buying an additional 1,110 shares during the quarter. Waddell & Reed Financial Inc. owned about 0.06% of Clorox worth $10,524,000 as of its most recent filing with the SEC.

Several other hedge funds also recently bought and sold shares of CLX. Macquarie Group Ltd. grew its stake in shares of Clorox by 437,400.0% in the second quarter. Macquarie Group Ltd. now owns 1,750,000 shares of the company’s stock valued at $236,688,000 after buying an additional 1,749,600 shares in the last quarter. Unigestion Holding SA acquired a new stake in shares of Clorox in the second quarter valued at about $73,819,000. Schroder Investment Management Group grew its stake in shares of Clorox by 107.7% in the first quarter. Schroder Investment Management Group now owns 959,288 shares of the company’s stock valued at $127,691,000 after buying an additional 497,427 shares in the last quarter. Morgan Stanley grew its stake in shares of Clorox by 44.2% in the second quarter. Morgan Stanley now owns 1,101,380 shares of the company’s stock valued at $148,962,000 after buying an additional 337,621 shares in the last quarter. Finally, FMR LLC grew its stake in shares of Clorox by 201.0% in the second quarter. FMR LLC now owns 472,179 shares of the company’s stock valued at $63,863,000 after buying an additional 315,298 shares in the last quarter. Institutional investors and hedge funds own 78.36% of the company’s stock.

A number of research analysts recently commented on CLX shares. ValuEngine raised Clorox from a “sell” rating to a “hold” rating in a report on Tuesday, June 26th. Bank of America increased their price target on Clorox from $130.00 to $140.00 and gave the company a “neutral” rating in a report on Monday, July 16th. Goldman Sachs Group downgraded Clorox from a “neutral” rating to a “sell” rating and reduced their price target for the company from $127.00 to $112.00 in a report on Tuesday, July 17th. They noted that the move was a valuation call. UBS Group started coverage on Clorox in a report on Wednesday, July 18th. They issued a “sell” rating and a $110.00 price target for the company. Finally, BMO Capital Markets reissued a “buy” rating and issued a $153.00 price target on shares of Clorox in a report on Friday, August 3rd. Four research analysts have rated the stock with a sell rating, eight have assigned a hold rating and four have given a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average target price of $137.21.

In related news, EVP Jon M. Balousek sold 3,354 shares of the firm’s stock in a transaction that occurred on Wednesday, August 29th. The stock was sold at an average price of $144.73, for a total value of $485,424.42. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, COO Dawn C. Willoughby sold 3,387 shares of the firm’s stock in a transaction that occurred on Wednesday, September 5th. The stock was sold at an average price of $148.01, for a total value of $501,309.87. The disclosure for this sale can be found here. In the last three months, insiders sold 29,268 shares of company stock worth $4,196,686. Company insiders own 1.00% of the company’s stock.

NYSE:CLX traded up $2.66 during trading hours on Friday, reaching $144.84. 1,065,111 shares of the stock were exchanged, compared to its average volume of 1,202,012. The company has a quick ratio of 0.67, a current ratio of 1.09 and a debt-to-equity ratio of 3.15. Clorox Co has a 52 week low of $113.57 and a 52 week high of $153.38. The company has a market cap of $19.21 billion, a PE ratio of 23.14, a P/E/G ratio of 3.11 and a beta of 0.36.

Clorox (NYSE:CLX) last released its earnings results on Thursday, August 2nd. The company reported $1.66 EPS for the quarter, topping analysts’ consensus estimates of $1.58 by $0.08. Clorox had a return on equity of 103.18% and a net margin of 13.44%. The company had revenue of $1.69 billion for the quarter, compared to the consensus estimate of $1.72 billion. During the same quarter last year, the business posted $1.53 EPS. Clorox’s quarterly revenue was up 2.7% compared to the same quarter last year. As a group, sell-side analysts expect that Clorox Co will post 6.41 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, November 16th. Investors of record on Wednesday, October 31st will be issued a $0.96 dividend. This represents a $3.84 annualized dividend and a dividend yield of 2.65%. The ex-dividend date of this dividend is Tuesday, October 30th. Clorox’s dividend payout ratio (DPR) is 61.34%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Further Reading: Diversification in Investing

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.